PMA device
Impella 2.5
Abiomed, Inc. · Temporary Non-Roller Type Left Heart Support Blood Pump (OZD, Class III) · First FDA decision Mar 23, 2015, newest Jun 23, 2025Cardiogenic shock
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
10
PMA pathway
Device trials
11
Naming "Impella 2.5"
MAUDE reports
449
Brand "Impella 2.5", since 2015
PubMed studies
199
Mentioning "Impella 2.5"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Impella 2.5
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 10 decisions filed under this name.
- Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LDPMA supplement
P140003-S125 · Decided Jun 23, 2025 · 88 days after receipt · Normal 180 Day Track
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
- Impella 2.5, Impella CP & CP with SmartAssist, Impella 5.0/LD, Impella 5.5 with SmartAssistPMA supplement
P140003-S096 · Decided Jul 8, 2022 · 108 days after receipt · Normal 180 Day Track No User Fee
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
- Impella 2.5 System, Impella CP System, Impella CP with SmartAssist System, Impella 5.0 System, Impella LD System,ImpellaPMA supplement
P140003-S088 · Decided Apr 19, 2022 · 257 days after receipt · Normal 180 Day Track
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
3 more FDA decisions with a free account
Older decisions: P140003-S074, P140003-S072, P140003-S001, P140003
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity)Coding analysisReview closedCAG-00285NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Impella 2.5", any status and sponsor, newest update first.
- Cardiogenic Shock Working Group RegistryRecruiting
Tufts Medical CenterAcademic, hospital or other
NCT04682483 · 20,000 participants (planned) · Start Dec 4, 2017 · Primary completion Dec 2027
Device: Acute Mechanical Circulatory Support Devices · For: Cardiogenic Shock
Sites: Weston, Florida; Chicago, Illinois; Indianapolis, Indiana · 22 sites in all
- Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular FunctionPivotal-lookingActive, not recruiting
Abiomed Inc.Public (JNJ)
NCT04763200 · 1,252 participants (planned) · Start Apr 13, 2021 · Primary completion Oct 2026
Device: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®; IABP Intra-aortic balloon pump · For: Left Ventricular Dysfunction; Coronary Artery Disease
Sites: Birmingham, Alabama; Phoenix, Arizona; Tucson, Arizona · 110 sites in all
Abiomed Inc.Public (JNJ)
NCT05820451 · 312 participants · Start Dec 15, 2022 · Primary completion Feb 22, 2024
Device: Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution; Impella RP with Sodium Bicarbonate used as purge solution · For: Cardiogenic Shock; High Risk PCI
Sites: Birmingham, Alabama; Tucson, Arizona; Little Rock, Arkansas · 20 sites in all
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Impella 2.5", and for the whole product code for context.
This brand
449 reports: 112 malfunction, 295 injury, 42 death
Whole product code OZD
46,892 reports: 17,926 malfunction, 23,020 injury, 5,943 death
Newest reports for this brand
1220648-2026-04572 · Received Mar 5, 2026 · Event dated Oct 9, 2025
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Malposition of Device
Patient problem as coded: Arrhythmia; Hemolysis; Ischemia; Pulmonary Edema; Renal Failure
- IMPELLA 2.5Malfunction
1220648-2025-31071 · Received Aug 6, 2025 · Event dated Jun 3, 2010
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Pumping Stopped
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- IMPELLA 2.5Malfunction
1220648-2025-30985 · Received Aug 4, 2025 · Event dated Mar 22, 2025
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Device Sensing Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Automated Impella Controller, Packaged. Primary user control interface for the Impella Catheter, catheter-based heart pump.Open, Classified
Z-0208-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0209-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Connect Optical AIC, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0210-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
22 more recall records with a free account
Published research
The most relevant PubMed records for "Impella 2.5"[tiab]. The summary above synthesizes these.
- Impella 2.5.
Raess DH, Weber DM · J Cardiovasc Transl Res · 2009
- A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
O'Neill WW, Kleiman NS, Moses J, et al. · Circulation · 2012Comparative Study, Multicenter Study
- Impella 2.5 Insertion: Which Artery to Access When Femoral Is not an Option?
Koutroumpakis E · JACC Case Rep · 2020Editorial
- Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series.
Bhat RA, Ali SM, Rathi A, et al. · Perfusion · 2023
- Impella-Induced Incessant Ventricular Tachycardia.
Kaki A, Subahi A, Shokr M, et al. · Ochsner J · 2019Case Reports
- Bridge to recovery using an Impella 2.5 device in a 3-year-old child.
Kuschnerus K, Starck C, Potapov E, et al. · Eur J Cardiothorac Surg · 2023Case Reports
- Impella CP-assisted balloon aortic valvuloplasty.
Megaly M, Jones P · J Cardiol Cases · 2016
- Abiomed Impella(®) 2.5 patient transport: lessons learned.
Griffith KE, Jenkins E · Perfusion · 2010
- Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.
Meraj PM, Doshi R, Schreiber T, et al. · J Interv Cardiol · 2017
- Left ventricular assistant device Impella 2.5 usage for patients undergoing high-risk PCI.
Palacios IF · Catheter Cardiovasc Interv · 2012Editorial, Comment
- Commentary on: Abiomed Impella(®) 2.5 patient transport: lessons learned.
Griffith K · Perfusion · 2010Comment, Interview
- Impella 2.5 in a patient with left main coronary artery occlusion.
Sanati HR, Amin A, Shakerian F, et al. · J Cardiol Cases · 2013
Other devices of this type
Also filed under product code OZD.
- Impella Ventricular Support SystemsAbiomed, Inc. · PMA 2023
- Impella CP with SmartAssistAbiomed, Inc. · PMA 2025
- Impella 2.5, Impella CP and CP with SmartAssistAbiomed, Inc. · PMA 2023
- Impella 5.5 with SmartAssist, Impella CP with SmartAssist, Purge CassetteAbiomed, Inc. · PMA 2025
- Impella Left Ventricular Support SystemsAbiomed, Inc. · PMA 2021
- Automated Impella ControllerAbiomed, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.